UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

MSRV envelope protein is a potent, endogenous and pathogenic agonist of human toll-like receptor 4: Relevance of GNbAC1 in multiple sclerosis treatment

Journal of neuroimmunology, 2016-02, Vol.291, p.29-38

2016

Link zum Volltext

Verfügbarkeit prüfen

GNbAC1, a Humanized Monoclonal Antibody Against the Envelope Protein of Multiple Sclerosis—Associated Endogenous Retrovirus: A First-in-Humans Randomized Clinical Study

Clinical therapeutics, 2012-12, Vol.34 (12), p.2268-2278

2012

Link zum Volltext

Verfügbarkeit prüfen

Light Chain–Induced Acute Renal Failure Can Be Reversed by Bortezomib-Doxorubicin-Dexamethasone in Multiple Myeloma: Results of a Phase II Study

Journal of clinical oncology, 2010-10, Vol.28 (30), p.4635-4641

2010

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of calreticulin exon 9 indel mutations in vascular risk patients

Thrombosis research, 2016-08, Vol.144, p.215-217

2016

Link zum Volltext

Verfügbarkeit prüfen

Significant survival impact of MACC1 polymorphisms in HER2 positive breast cancer patients

European journal of cancer (1990), 2014-08, Vol.50 (12), p.2134-2141

2014

Link zum Volltext

Verfügbarkeit prüfen

A common variant of the MACC1 gene is significantly associated with overall survival in colorectal cancer patients

BMC cancer, 2012-01, Vol.12 (1), p.20-20, Article 20

2012

Link zum Volltext

Verfügbarkeit prüfen

Human Endogenous Retrovirus and Neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy

EBioMedicine, 2016-04, Vol.6, p.190-198

2016

Link zum Volltext

Verfügbarkeit prüfen

Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications

Journal of hematology and oncology, 2016-04, Vol.9 (39), p.39-16, Article 39

2016

Link zum Volltext

Verfügbarkeit prüfen

Association of a common genetic variant of the IGF-1 gene with event-free survival in patients with HER2-positive breast cancer

Journal of cancer research and clinical oncology, 2013-03, Vol.139 (3), p.491-498

2013

Link zum Volltext

Verfügbarkeit prüfen

Pathologic Complete Response With Six Compared With Three Cycles of Neoadjuvant Epirubicin Plus Docetaxel and Granulocyte Colony-Stimulating Factor in Operable Breast Cancer: Results of ABCSG-14

Journal of clinical oncology, 2007-05, Vol.25 (15), p.2012-2018

2007

Link zum Volltext

Verfügbarkeit prüfen

Human Monoclonal Antibodies as a New Class of Antiinfective Compounds

Clinical & developmental immunology, 2013-01, Vol.2013, p.297120-2

2013

Link zum Volltext

Verfügbarkeit prüfen

Vaccination of Cystic Fibrosis Patients Against Pseudomonas aeruginosa Reduces the Proportion of Patients Infected and Delays Time to Infection

The Pediatric infectious disease journal, 2004-06, Vol.23 (6), p.504-510

2004

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset

Annals of oncology, 2014-12, Vol.25 (12), p.2378-2385

2014

Link zum Volltext

Verfügbarkeit prüfen

Azacitidine in CMML: Matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival

Leukemia research, 2014-04, Vol.38 (4), p.475-483

2014

Link zum Volltext

Verfügbarkeit prüfen

Complications after oesophagectomy with possible contribution of neoadjuvant therapy including an EGFR-antibody to a fatal outcome

World journal of surgical oncology, 2007-10, Vol.5 (1), p.114-114, Article 114

2007

Link zum Volltext

Verfügbarkeit prüfen

Azacitidine in patients with WHO-defined AML - results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group

Journal of hematology and oncology, 2013-04, Vol.6 (1), p.32-32, Article 32

2013

Link zum Volltext

Verfügbarkeit prüfen

Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma

European journal of cancer (1990), 2016-05, Vol.58, p.112-121

2016

Link zum Volltext

Verfügbarkeit prüfen

Azacitidine frontline therapy for unfit acute myeloid leukemia patients: Clinical use and outcome prediction

Leukemia research, 2015-03, Vol.39 (3), p.296-306

2015

Link zum Volltext

Verfügbarkeit prüfen

2-18fluoro-deoxy-D-glucose Positron Emission Tomography Is a Reliable Predictor for Viable Tumor in Postchemotherapy Seminoma: An Update of the Prospective Multicentric SEMPET Trial

Journal of clinical oncology, 2004-03, Vol.22 (6), p.1034-1039

2004

Link zum Volltext

Verfügbarkeit prüfen

Different types of K-Ras mutations are conversely associated with overall survival in patients with colorectal cancer

Oncology reports, 2009-05, Vol.21 (5), p.1283-1287

2009

Link zum Volltext

Verfügbarkeit prüfen

Nilotinib as frontline and second-line therapy in chronic myeloid leukemia: Open questions

Critical reviews in oncology/hematology, 2012-06, Vol.82 (3), p.370-377

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieThe Journal Of Infectious Diseases

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(27)
Life Sciences & Biomedicine
(27)
Science & Technology
(27)
Female
(20)
Male
(17)
Middle Aged
(17)
Aged
(16)
Biological And Medical Sciences
(14)
Oncology
(14)
Adult
(12)
Medical Sciences
(12)
Aged, 80 And Over
(8)
Hematology
(7)
Hematology, Oncology And Palliative Medicine
(7)
Prognosis
(7)
Tumors
(7)
Azacitidine
(6)
Treatment Outcome
(6)
Antimetabolites, Antineoplastic - Therapeutic Use
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

MSRV envelope protein is a potent, endogenous and pathogenic agonist of human toll-like receptor 4: Relevance of GNbAC1 in multiple sclerosis treatment

GNbAC1, a Humanized Monoclonal Antibody Against the Envelope Protein of Multiple Sclerosis—Associated Endogenous Retrovirus: A First-in-Humans Randomized Clinical Study

A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients — A twelve month follow-up

Light Chain–Induced Acute Renal Failure Can Be Reversed by Bortezomib-Doxorubicin-Dexamethasone in Multiple Myeloma: Results of a Phase II Study

Prevalence of calreticulin exon 9 indel mutations in vascular risk patients

Significant survival impact of MACC1 polymorphisms in HER2 positive breast cancer patients

Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease

A common variant of the MACC1 gene is significantly associated with overall survival in colorectal cancer patients

Human Endogenous Retrovirus and Neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications

Association of a common genetic variant of the IGF-1 gene with event-free survival in patients with HER2-positive breast cancer

Pathologic Complete Response With Six Compared With Three Cycles of Neoadjuvant Epirubicin Plus Docetaxel and Granulocyte Colony-Stimulating Factor in Operable Breast Cancer: Results of ABCSG-14

Human Monoclonal Antibodies as a New Class of Antiinfective Compounds

Vaccination of Cystic Fibrosis Patients Against Pseudomonas aeruginosa Reduces the Proportion of Patients Infected and Delays Time to Infection

Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset

Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group

Azacitidine in CMML: Matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival

Complications after oesophagectomy with possible contribution of neoadjuvant therapy including an EGFR-antibody to a fatal outcome

Azacitidine in patients with WHO-defined AML - results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group

Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma

Azacitidine frontline therapy for unfit acute myeloid leukemia patients: Clinical use and outcome prediction

2-18fluoro-deoxy-D-glucose Positron Emission Tomography Is a Reliable Predictor for Viable Tumor in Postchemotherapy Seminoma: An Update of the Prospective Multicentric SEMPET Trial

Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study

Different types of K-Ras mutations are conversely associated with overall survival in patients with colorectal cancer

Nilotinib as frontline and second-line therapy in chronic myeloid leukemia: Open questions

Aktive Filter

Suchergebnisse filtern